More than 15,000 women a year who have breast cancer in the UK would benefit from tests that analyse DNA for changes or mutations, a study has suggested.
Having a patient’s entire genetic readout using whole genome sequencing could help guide personalised treatments and open up recruitment to clinical trials, according to researchers.
